N1
N1 is a privately held early-stage venture capital firm founded in 2019 that manages $60M across two funds, backing AI, healthtech, and frontier-tech founders across Europe and the US with first checks of $100K–$1M.
- Company typePrivate
- Founded2019
- HeadquartersPrague, Czechia
- Headcount1–10
- GTM typeB2B
- OfferingServices
What N1 does
N1 is a privately held early-stage venture capital firm founded in 2019 that backs AI, healthtech, and frontier-tech founders across Europe and the US. The firm is led by managing partners Marek Moravec and Jaroslav Trojan, operates a dual-hub structure with an office in San Francisco and a regional presence in Prague, and manages $60 million across two funds—a main fund and a dedicated U-Tech vehicle focused on deep-tech and engineering founders. Typical first checks are $100K–$1M, and the firm positions itself as an operator-investor, citing the Taikun exit to Cloudera as evidence of hands-on founder experience.
The firm's offering is not a software product but a capital-plus-support platform: in addition to equity capital, N1 provides transatlantic network access, co-investment alongside top-tier US funds (including Y Combinator and Credo Ventures), and direct help with relocation, fundraising, and US-market expansion. The disclosed portfolio spans AI (Myriad AI, Scalpel AI), insurance/healthtech (TrueClaim), digital health (Hedepy), consumer health (Snuggs), and cloud/data infrastructure (Taikun), with at least one full exit and one partial exit referenced.
Revenue is generated through standard venture fund economics: management fees on committed capital across the two funds, plus carried interest on realized exits. Deal flow is primarily relationship- and co-investor-referred rather than driven by paid marketing, and the firm's website (n1.rocks) functions as the central brand and credibility surface.
N1 firmographics
Firmographics- Name
- N1
- Legal name
- N1
- Website
- https://n1.rocks
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- N1 is a privately held early-stage venture capital firm founded in 2019 that manages $60M across two funds, backing AI, healthtech, and frontier-tech founders across Europe and the US with first checks of $100K–$1M.
- Ownership category
- akta.pro rank
Where N1 is headquartered
LocationHeadquarters
- HQ city
- Prague
- HQ country
- Czechia
- HQ region
- Europe
Offices2 records
Markets served
N1 business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Venture capital fund management: N1 manages $60M across two funds (including a U-Tech fund) focused on AI and healthcare. Revenue is generated through typical VC fund economics: management fees on committed capital and carried interest on exits from portfolio investments (e.g., Taikun exited to Cloudera; Snuggs partially exited).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Typical first investment: $100K–$1M per portfolio company |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
N1 product offering
Product offeringCore offering
N1 is an early-stage venture capital firm that invests capital in AI, healthtech, and frontier-tech founders across Europe and the US. The firm manages $60M across two funds, providing typical first investments of $100K–$1M in exchange for equity, supplemented by hands-on operator support, transatlantic network access, and US-market expansion assistance. A separate U-Tech fund is dedicated to deep-tech/engineering founders.
Product overview
N1 does not offer a unified software product or a platform-plus-modules architecture. It is an early-stage venture capital firm that invests in AI and Healthtech founders across Europe and the US. The closest comparable named offerings it surfaces are its investment vehicles and programs (a main fund and a separate U-Tech fund) and a portfolio of backed companies (including Myriad AI, TrueClaim, and Scalpel AI) rather than discrete N1-branded software products or modules. Because N1 itself does not ship a product, there are no N1 software sub-products, modules, or add-ons to enumerate here.
Differentiator
Problem solved
Functional benefit
Brands
- U-Tech fund: A dedicated fund within N1's portfolio, listed separately on the firm's website navigation.
Products and services
- N1 main fund (AI & Healthtech) Early-stage venture capital fund focused on AI and Healthtech founders across Europe and the US, providing first investments of $100K–$1M in exchange for equity, plus operator support and transatlantic network access.
- N1 U-Tech fund Dedicated venture capital fund within N1 targeting deep-tech and engineering (U-Tech) founders, providing capital and operator support alongside the main AI/Healthtech fund.
Quantifiable outcome
- Successful exit of portfolio company Taikun to Cloudera (acquisition)
- +2 more outcomes
Companies that use N1
Customer profileNamed customers6 records
Ideal customer profiles2 records
N1 technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
N1 partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights4 records
N1 competitors and assessment
Company assessmentDirect peers
- Balderton Capital: London-based early-stage European VC backing tech founders from seed onwards. Comparable in stage, geography, and pan-European deal sourcing.
- LocalGlobe: London-based seed-stage VC focused on European founders with global ambition. Highly comparable in stage, geography, and the 'seed-first, founder-first' orientation.
- Credo Ventures: Prague-based early-stage VC focused on Central European founders, with similar check sizes and stage. Credo is explicitly listed as a flagship co-investor of N1, making it the closest comparable in geography, stage, and thesis.
- Speedinvest: Vienna-based early-stage European VC with sector-vertical funds (including digital health and deep tech) and multi-hundred-million AUM. Highly comparable in stage, structure, and thematic focus.
- Index Ventures: London/San Francisco/Geneva-headquartered early-stage VC with a transatlantic footprint and focus on software, AI, and healthtech. Comparable in stage and the Europe-to-US bridge model that N1 is attempting.
- Atomico: London-based European early-stage VC founded by a former operator, investing across sectors including AI and frontier tech. Comparable in stage, operator-led DNA, and pan-European sourcing.
- Earlybird Venture Capital: Berlin-based European early-stage VC with a health-focused fund and a digital/tech fund. Comparable in stage, structure, and healthtech/tech vertical specialization.
- Point Nine Capital: Berlin-based early-stage European VC focused on B2B SaaS and AI from day one. Comparable in stage, check size, and operator-supportive model.
- Notion Capital: London-based early-stage European VC focused on B2B SaaS, AI, and enterprise software. Comparable in stage, check size, and Europe-anchored thesis.
- First Round Capital: US seed-stage VC famous for community-driven founder support and operator-friendly model. Comparable in stage, check size, and the strong emphasis on hands-on portfolio support.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
N1 social profiles
Digital presenceN1 financial estimates
Financial estimateRevenue estimate
Valuation estimate
N1 leadership team
Management profileNumber of profiles
Profiles2 records
N1 subsidiaries and ownership
Company hierarchySubsidiaries1 record
N1 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
N1 M&A and investment
M&A and investmentM&A
Investments63 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about N1
What does N1 do?
N1 is an early-stage venture capital firm that invests capital in AI, healthtech, and frontier-tech founders across Europe and the US. The firm manages $60M across two funds, providing typical first investments of $100K–$1M in exchange for equity, supplemented by hands-on operator support, transatlantic network access, and US-market expansion assistance. A separate U-Tech fund is dedicated to deep-tech/engineering founders.
Is N1 a public or private company?
N1 is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was N1 founded?
N1 was founded in 2019. It employs 1 to 10 people.
Where is N1 based?
N1 is headquartered in Prague, Czechia, in the Europe region.
How does N1 make money?
One revenue line is on record: venture capital fund management.
Who are N1's main competitors?
Direct peers on record are Balderton Capital, LocalGlobe, Credo Ventures, Speedinvest, Index Ventures, Atomico, Earlybird Venture Capital, Point Nine Capital, Notion Capital and First Round Capital.
Does N1 have an API?
No public API is recorded for N1.